These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 24419137)

  • 1. Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study.
    Sozzi G; Boeri M; Rossi M; Verri C; Suatoni P; Bravi F; Roz L; Conte D; Grassi M; Sverzellati N; Marchiano A; Negri E; La Vecchia C; Pastorino U
    J Clin Oncol; 2014 Mar; 32(8):768-73. PubMed ID: 24419137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening.
    Sestini S; Boeri M; Marchiano A; Pelosi G; Galeone C; Verri C; Suatoni P; Sverzellati N; La Vecchia C; Sozzi G; Pastorino U
    Oncotarget; 2015 Oct; 6(32):32868-77. PubMed ID: 26451608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline computed tomography screening and blood microRNA predict lung cancer risk and define adequate intervals in the BioMILD trial.
    Pastorino U; Boeri M; Sestini S; Sabia F; Milanese G; Silva M; Suatoni P; Verri C; Cantarutti A; Sverzellati N; Corrao G; Marchianò A; Sozzi G
    Ann Oncol; 2022 Apr; 33(4):395-405. PubMed ID: 35091076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum and blood based biomarkers for lung cancer screening: a systematic review.
    Chu GCW; Lazare K; Sullivan F
    BMC Cancer; 2018 Feb; 18(1):181. PubMed ID: 29439651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Jonas DE; Reuland DS; Reddy SM; Nagle M; Clark SD; Weber RP; Enyioha C; Malo TL; Brenner AT; Armstrong C; Coker-Schwimmer M; Middleton JC; Voisin C; Harris RP
    JAMA; 2021 Mar; 325(10):971-987. PubMed ID: 33687468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial.
    Pastorino U; Rossi M; Rosato V; Marchianò A; Sverzellati N; Morosi C; Fabbri A; Galeone C; Negri E; Sozzi G; Pelosi G; La Vecchia C
    Eur J Cancer Prev; 2012 May; 21(3):308-15. PubMed ID: 22465911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment.
    Pinsky PF; Gierada DS; Black W; Munden R; Nath H; Aberle D; Kazerooni E
    Ann Intern Med; 2015 Apr; 162(7):485-91. PubMed ID: 25664444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer.
    Boeri M; Verri C; Conte D; Roz L; Modena P; Facchinetti F; Calabrò E; Croce CM; Pastorino U; Sozzi G
    Proc Natl Acad Sci U S A; 2011 Mar; 108(9):3713-8. PubMed ID: 21300873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten-year results of the Multicentric Italian Lung Detection trial demonstrate the safety and efficacy of biennial lung cancer screening.
    Pastorino U; Sverzellati N; Sestini S; Silva M; Sabia F; Boeri M; Cantarutti A; Sozzi G; Corrao G; Marchianò A
    Eur J Cancer; 2019 Sep; 118():142-148. PubMed ID: 31336289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial.
    Aberle DR; Abtin F; Brown K
    J Clin Oncol; 2013 Mar; 31(8):1002-8. PubMed ID: 23401434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overdiagnosis in low-dose computed tomography screening for lung cancer.
    Patz EF; Pinsky P; Gatsonis C; Sicks JD; Kramer BS; Tammemägi MC; Chiles C; Black WC; Aberle DR;
    JAMA Intern Med; 2014 Feb; 174(2):269-74. PubMed ID: 24322569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-Test: a blood test for lung cancer early detection.
    Montani F; Marzi MJ; Dezi F; Dama E; Carletti RM; Bonizzi G; Bertolotti R; Bellomi M; Rampinelli C; Maisonneuve P; Spaggiari L; Veronesi G; Nicassio F; Di Fiore PP; Bianchi F
    J Natl Cancer Inst; 2015 Jun; 107(6):djv063. PubMed ID: 25794889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of Low-Dose Computed Tomography With a Plasma-Based Biomarker for Lung Cancer Screening in China.
    Zhao Z; Wang Y; Wu W; Yang Y; Du L; Dong H
    JAMA Netw Open; 2022 May; 5(5):e2213634. PubMed ID: 35608858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood microRNA testing in participants with suspicious low-dose CT findings: follow-up of the BioMILD lung cancer screening trial.
    Boeri M; Sabia F; Ledda RE; Balbi M; Suatoni P; Segale M; Zanghì A; Cantarutti A; Rolli L; Valsecchi C; Corrao G; Marchianò A; Pastorino U; Sozzi G
    Lancet Reg Health Eur; 2024 Nov; 46():101070. PubMed ID: 39319217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung cancer screening with low-dose spiral computed tomography: evidence from a pooled analysis of two Italian randomized trials.
    Infante M; Sestini S; Galeone C; Marchianò A; Lutman FR; Angeli E; Calareso G; Pelosi G; Sozzi G; Silva M; Sverzellati N; Cavuto S; La Vecchia C; Santoro A; Alloisio M; Pastorino U
    Eur J Cancer Prev; 2017 Jul; 26(4):324-329. PubMed ID: 27222939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography.
    Infante M; Cavuto S; Lutman FR; Passera E; Chiarenza M; Chiesa G; Brambilla G; Angeli E; Aranzulla G; Chiti A; Scorsetti M; Navarria P; Cavina R; Ciccarelli M; Roncalli M; Destro A; Bottoni E; Voulaz E; Errico V; Ferraroli G; Finocchiaro G; Toschi L; Santoro A; Alloisio M;
    Am J Respir Crit Care Med; 2015 May; 191(10):1166-75. PubMed ID: 25760561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation.
    Humphrey LL; Deffebach M; Pappas M; Baumann C; Artis K; Mitchell JP; Zakher B; Fu R; Slatore CG
    Ann Intern Med; 2013 Sep; 159(6):411-420. PubMed ID: 23897166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective use of low-dose computed tomography lung cancer screening.
    Jeffers CD; Pandey T; Jambhekar K; Meek M
    Curr Probl Diagn Radiol; 2013; 42(5):220-30. PubMed ID: 24070715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodal lung cancer screening using the ITALUNG biomarker panel and low dose computed tomography. Results of the ITALUNG biomarker study.
    Carozzi FM; Bisanzi S; Carrozzi L; Falaschi F; Lopes Pegna A; Mascalchi M; Picozzi G; Peluso M; Sani C; Greco L; Ocello C; Paci E;
    Int J Cancer; 2017 Jul; 141(1):94-101. PubMed ID: 28387927
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 27.